Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas

Area of Science:

• Oncology
• Genetics
• Hematology

Background:

• Diffuse Large B-cell Lymphoma (DLBCL) is a complex disease with varied clinical and biological characteristics.
• Previous understanding suggested DLBCL heterogeneity, but distinct genomic and phenotypic differences between nodal and extranodal origins were not fully elucidated.

Purpose of the Study:

• To investigate and compare the genomic and phenotypic profiles of primary nodal and extranodal Diffuse Large B-cell Lymphomas.
• To identify potential novel genome and proteome-based signatures that can differentiate these two DLBCL subtypes.

Main Methods:

• Conventional Comparative Genomic Hybridization (CGH) was employed to analyze chromosomal aberrations in 18 nodal, 13 extranodal, and 5 mixed DLBCL cases.
• Immunohistochemistry using antibodies for GCET1, MUM1, CD10, BCL6, and FOXP1 was performed to classify DLBCLs based on the Choi algorithm.
• High-resolution 21K BAC array CGH was utilized for further genomic analysis on 12 independent extranodal DLBCL cases.

Main Results:

• Significant differences in chromosomal aberrations were observed between nodal and extranodal DLBCLs, including gains in 1p, 7p, 12q, 22q, and chromosome X, and losses in chromosome 4, 6q, and 18q.
• Nodal DLBCLs showed a higher tendency for 18q amplification and BCL2 protein overexpression compared to extranodal and mixed types.
• The observed genomic differences were independent of the proportions of Germinal Center B-cell (GCB) versus Activated B-cell (ABC) subtypes.

Conclusions:

• Primary nodal and extranodal DLBCLs possess distinct genomic and phenotypic signatures.
• These findings provide the first demonstration of genome and proteome-based signatures that can potentially differentiate between nodal and extranodal DLBCLs.